Decreased incidence of HLA-A11 and increased incidence of HLA-B8 in a North American population of insulin dependent diabetics.
Seventy-four North American Caucasian insulin dependent diabetics are presented and compared to 100 healthy controls relative to HLA-A and B locus antigens. A highly significant increase in the frequency of HLA-B8 was found (p < 0.01, relative risk 3.67). The presence of HLA-A11 conferred statistically significant protection against disease development in these patients (p < 0.01, relative risk 0.19). There was no significant difference in the frequency of HLA-B7, B8, or B15 between the study and control groups. The patient group does show a significant increase in heterozygosity for HLA-B8 and HLA-B15 when compared to healthy controls (p < 0.05, relative risk 7.17). Increased incidence of HLA-B18 has previously been noted in French and English populations only. Since most of our HLA-B18 patients are of English extraction, it is concluded tht the altered incidence of the HLA-B18 allele in insulin dependent diabetes does persist in this migratory European population.
D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D009656:North America; D012306:Risk
D006680:HLA Antigens; D007328:Insulin